Grifols (GRFS) Net Cash Flow (2010 - 2020)

Grifols (GRFS) reported Net Cash Flow of -$130.2 million for Q1 2020, up 75.96% on a YoY basis from -$74.0 million in Q2 2019, and up 59.92% quarter-over-quarter from -$324.9 million in Q4 2019.

Grifols (GRFS) Net Cash Flow (2010 - 2020) Analysis & Trends

Grifols has reported Net Cash Flow for 10 years, with the latest figure at -$130.2 million in Q1 2020.

  • For the quarter ending Q1 2020, Net Cash Flow rose 75.96% year-over-year to -$130.2 million; the trailing twelve-month figure through Dec 2025 stood at $0.0 (changed 0.0% YoY), and the FY2025 full-year result was -$71.0 million, down 115.49% from the prior year.
  • Net Cash Flow for Q1 2020 stood at -$130.2 million, up from -$324.9 million in the prior quarter.
  • The five-year high for Net Cash Flow was $4.9 billion in Q4 2017, with the low at -$604.2 million in Q3 2016.
  • Historically, Net Cash Flow has averaged $751.8 million across 5 years, with a median of -$72.0 million in 2016.
  • Annual changes were most pronounced in 2016 — Net Cash Flow plunged 322.73% — and 2017, when it jumped 6845.21%.
  • Grifols' Net Cash Flow stood at -$72.0 million in 2016, then jumped by 6845.21% to $4.9 billion in 2017, then slumped by 72.95% to $1.3 billion in 2018, then plunged by 124.72% to -$324.9 million in 2019, then soared by 59.92% to -$130.2 million in 2020.
  • The last three Net Cash Flow figures came in at -$130.2 million (Q1 2020), -$324.9 million (Q4 2019), and -$541.8 million (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 210.32 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -2.05 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 2.00 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 4.17 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -9.27 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 75.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 544.00 Mn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -587.00 Mn
10 Grifols 6.05 Bn 5.09 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -130.24 Mn
Mar 31, 2020 -130.24 Mn
Dec 31, 2019 -324.92 Mn
Dec 31, 2019 -324.92 Mn
Mar 31, 2019 -541.80 Mn
Mar 31, 2019 -541.80 Mn
Dec 31, 2018 1.31 Bn
Dec 31, 2018 1.31 Bn
Jun 30, 2018 -530.10 Mn
Jun 30, 2018 -530.10 Mn
Mar 31, 2018 249.20 Mn
Mar 31, 2018 249.20 Mn
Dec 31, 2017 4.86 Bn
Dec 31, 2017 4.86 Bn
Jun 30, 2017 247.39 Mn
Jun 30, 2017 247.39 Mn
Mar 31, 2017 3.80 Bn
Mar 31, 2017 3.80 Bn
Dec 31, 2016 -72.03 Mn
Dec 31, 2016 -72.03 Mn